The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Cytokines in psoriasis
Open accessAbstract
Psoriasis is a common inflammatory skin disease with an incompletely understood etiology. The disease is characterized by red, scaly and well-demarcated skin lesions formed by the hyperproliferation of epidermal keratinocytes. This hyperproliferation is driven by cytokines secreted by activated resident immune cells, an infiltrate of T cells, dendritic cells and cells of the innate immune system, as well as the keratinocytes themselves. Psoriasis has a strong hereditary character and has a complex genetic background. Genome-wide association studies have identified polymorphisms within or near a number of genes encoding cytokines, cytokine receptors or elements of their signal transduction pathways, further implicating these cytokines in the psoriasis pathomechanism. A considerable number of inflammatory cytokines have been shown to be elevated in lesional psoriasis skin, and the serum concentrations of a subset of these also correlate with psoriasis disease severity. The combined effects of the cytokines found in psoriasis lesions likely explain most of the clinical features of psoriasis, such as the hyperproliferation of keratinocytes, increased neovascularization and skin inflammation. Thus, understanding which cytokines play a pivotal role in the disease process can suggest potential therapeutic targets. A number of cytokines have been therapeutically targeted with success, revolutionizing treatment of this disease. Here we review a number of key cytokines implicated in the pathogenesis of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.339 · Cited by 2,592
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Understanding the mechanism of IL-1β secretion
Lopez-Castejon, G., & Brough, D. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.10.001 · Cited by 1,519
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
for the Collaborative Association Study of Psoriasis, Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D., Gudjonsson, J. E., Li, Y., Tejasvi, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.311 · Cited by 1,409
Schweiger, D., Baufeld, C., Drescher, P., Oltrogge, B., Höpfner, S., Mess, A., Lüttke, J., Rippke, F., Filbry, A., & Max, H. (2013) · Skin Pharmacology and Physiology · doi:10.1159/000348473 · Cited by 1,346
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,124
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P., & Krueger, J. G. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701213 · Cited by 1,082
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966 · cited 2×
“This potent antiinflammatory activity of IL-37b was critically dependent on nuclear translocation [50,51], a property IL-37 may share with IL-1α [21] and IL-33 [52].”
BackgroundBrodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Wolk, K., Witte, E., Wallace, E., Döcke, W., Kunz, S., Asadullah, K., Volk, H., Sterry, W., & Sabat, R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535503 · Cited by 922
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
IL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
Arican, O., Aral, M., Sasmaz, S., & Ciragil, P. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.273 · Cited by 805
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., & Gilliet, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 740
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
Maddur, M. S., Miossec, P., Kaveri, S. V., & Bayry, J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.044 · Cited by 619
Teunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570
Therapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544 · cited 2×
“However, IFN-γ likely contributes to the cytokine storm in psoriasis [7] by, at the very least, aiding and abetting other cytokines, in particular, IL-17A [25,120], as well as playing a role in priming APCs [25], which drives IL-1/IL-23 production to augment Th17 responses.”
BackgroundThe Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1β by Keratinocytes
Feldmeyer, L., Keller, M., Niklaus, G., Hohl, D., Werner, S., & Beer, H.-D. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.074 · Cited by 544 · cited 2×
“Cell stress, infection or local danger signals trigger the assembly of inflammasome complexes [15,18,19], which activate caspase-1, which in turn cleaves pro-IL-1β to its active form.”
BackgroundOnoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529
Sa, S. M., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I., Winer, J., Modrusan, Z., Danilenko, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2229 · Cited by 514
Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B., & Krueger, J. G. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00749.x · Cited by 485
Kryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Wang, Y., Liu, Y., Welling, T. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4733 · Cited by 470
Self-citationGroß, O., Yazdi, A. S., Thomas, C. J., Masin, M., Heinz, L. X., Guarda, G., Quadroni, M., Drexler, S. K., & Tschopp, J. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.018 · Cited by 460
Piskin, G., Sylva-Steenland, R. M. R., Bos, J. D., & Teunissen, M. B. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1908 · Cited by 454
Carrier, Y., Ma, H.-L., Ramon, H. E., Napierata, L., Small, C., O'Toole, M., Young, D. A., Fouser, L. A., Nickerson-Nutter, C., Collins, M., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.234 · Cited by 425
Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D., & Sims, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400117200 · Cited by 419
Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H. D., & Döcke, W. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1476 · Cited by 415
Capon, F., Di Meglio, P., Szaub, J., Prescott, N. J., Dunster, C., Baumber, L., Timms, K., Gutin, A., Abkevic, V., Burden, A. D., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0397-0 · Cited by 408
Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
Tortola, L., Rosenwald, E., Abel, B., Blumberg, H., Schäfer, M., Coyle, A. J., Renauld, J.-C., Werner, S., Kisielow, J., & Kopf, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63451 · Cited by 405
Li, B., Tsoi, L. C., Swindell, W. R., Gudjonsson, J. E., Tejasvi, T., Johnston, A., Ding, J., Stuart, P. E., Xing, X., Kochkodan, J. J., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.28 · Cited by 397
Self-citationImmunopathogenic mechanisms in psoriasis
GUDJONSSON, J. E., JOHNSTON, A., SIGMUNDSDOTTIR, H., & VALDIMARSSON, H. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02310.x · Cited by 397
Self-citationVillanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G. K., Chapman, A., Smith, C. H., Di Meglio, P., & Nestle, F. O. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.477 · Cited by 386
Kupper, T. S., Ballard, D. W., Chua, A. O., McGuire, J. S., Flood, P. M., Horowitz, M. C., Langdon, R., Lightfoot, L., & Gubler, U. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.2095 · Cited by 386
Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family
Kumar, S., McDonnell, P. C., Lehr, R., Tierney, L., Tzimas, M. N., Griswold, D. E., Capper, E. A., Tal-Singer, R., Wells, G. I., Doyle, M. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10308 · Cited by 364
Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12110 · Cited by 360
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., Oostingh, G. J., Pfaller, T., Pixner, C., Posselt, G., et al. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0288 · Cited by 357
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation
Blumberg, H., Dinh, H., Trueblood, E. S., Pretorius, J., Kugler, D., Weng, N., Kanaly, S. T., Towne, J. E., Willis, C. R., Kuechle, M. K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070157 · Cited by 348
The precursor form of IL-1α is an intracrine proinflammatory activator of transcription
Werman, A., Werman-Venkert, R., White, R., Lee, J.-K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A., & Apte, R. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308705101 · Cited by 346
Four New Members Expand the Interleukin-1 Superfamily
Smith, D. E., Renshaw, B. R., Ketchem, R. R., Kubin, M., Garka, K. E., & Sims, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1169 · Cited by 341
Res, P. C. M., Piskin, G., de Boer, O. J., van der Loos, C. M., Teeling, P., Bos, J. D., & Teunissen, M. B. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014108 · Cited by 328
Albanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J.-D., Parmentier, M., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080129 · Cited by 327
Towne, J. E., Renshaw, B. R., Douangpanya, J., Lipsky, B. P., Shen, M., Gabel, C. A., & Sims, J. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267922 · Cited by 326
The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29
Commins, S., Steinke, J. W., & Borish, L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.026 · Cited by 321
Johnston, A., Xing, X., Guzman, A. M., Riblett, M., Loyd, C. M., Ward, N. L., Wohn, C., Prens, E. P., Wang, F., Maier, L. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003162 · Cited by 319
Self-citationKeratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
Johnston, A., Fritz, Y., Dawes, S. M., Diaconu, D., Al-Attar, P. M., Guzman, A. M., Chen, C. S., Fu, W., Gudjonsson, J. E., McCormick, T. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201505 · Cited by 308
Self-citationSuárez-Fariñas, M., Li, K., Fuentes-Duculan, J., Hayden, K., Brodmerkel, C., & Krueger, J. G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.184 · Cited by 305
Zaba, L. C., Suárez-Fariñas, M., Fuentes-Duculan, J., Nograles, K. E., Guttman-Yassky, E., Cardinale, I., Lowes, M. A., & Krueger, J. G. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.046 · Cited by 303
IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin
Foster, A. M., Baliwag, J., Chen, C. S., Guzman, A. M., Stoll, S. W., Gudjonsson, J. E., Ward, N. L., & Johnston, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301481 · Cited by 302
Self-citationDebets, R., Timans, J. C., Homey, B., Zurawski, S., Sana, T. R., Lo, S., Wagner, J., Edwards, G., Clifford, T., Menon, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1440 · Cited by 286
Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
Nair, R. P., Ruether, A., Stuart, P. E., Jenisch, S., Tejasvi, T., Hiremagalore, R., Schreiber, S., Kabelitz, D., Lim, H. W., Voorhees, J. J., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701255 · Cited by 282
IL-17 Enhances Chemokine Gene Expression through mRNA Stabilization
Hartupee, J., Liu, C., Novotny, M., Li, X., & Hamilton, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4135 · Cited by 282
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Untangling the Complex Web of IL-4– and IL-13–Mediated Signaling Pathways
Wills-Karp, M., & Finkelman, F. D. (2008) · Science Signaling · doi:10.1126/scisignal.1.51.pe55 · Cited by 274
Hijnen, D., Knol, E. F., Gent, Y. Y., Giovannone, B., Beijn, S. J. P., Kupper, T. S., Bruijnzeel-Koomen, C. A. F. M., & Clark, R. A. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.456 · Cited by 271
Ortega, C., Fernández-A, S., Carrillo, J. M., Romero, P., Molina, I. J., Moreno, J. C., & Santamaría, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109046 · Cited by 269
Gudjonsson, J. E., Johnston, A., Dyson, M., Valdimarsson, H., & Elder, J. T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700807 · Cited by 266
Self-citationKumar, S., Hanning, C. R., Brigham-Burke, M. R., Rieman, D. J., Lehr, R., Khandekar, S., Kirkpatrick, R. B., Scott, G. F., Lee, J. C., Lynch, F. J., et al. (2002) · Cytokine · doi:10.1006/cyto.2002.0873 · Cited by 259
IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions
D'Erme, A. M., Wilsmann-Theis, D., Wagenpfeil, J., Hölzel, M., Ferring-Schmitt, S., Sternberg, S., Wittmann, M., Peters, B., Bosio, A., Bieber, T., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.532 · Cited by 252
A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity
Bufler, P., Azam, T., Gamboni-Robertson, F., Reznikov, L. L., Kumar, S., Dinarello, C. A., & Kim, S.-H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519099 · Cited by 251
Campion, G. V., Lebsack, M. E., Lookabaugh, J., & Gordon, G. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390704 · Cited by 247
Rich, P., Sigurgeirsson, B., Thaçi, D., Ortonne, J. ‐., Paul, C. F., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12112 · Cited by 244
The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines
Sharma, S., Kulk, N., Nold, M. F., Gräf, R., Kim, S.-H., Reinhardt, D., Dinarello, C. A., & Bufler, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5477 · Cited by 242
Gudjonsson, J. E., Ding, J., Johnston, A., Tejasvi, T., Guzman, A. M., Nair, R. P., Voorhees, J. J., Abecasis, G. R., & Elder, J. T. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.36 · Cited by 237
Self-citationNatsuaki, Y., Egawa, G., Nakamizo, S., Ono, S., Hanakawa, S., Okada, T., Kusuba, N., Otsuka, A., Kitoh, A., Honda, T., et al. (2014) · Nature Immunology · doi:10.1038/ni.2992 · Cited by 236
Expression of Interleukin-12 is Increased in Psoriatic Skin
Yawalkar, N., Karlen, S., Hunger, R., Brand, C. U., & Braathen, L. R. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00446.x · Cited by 221
IL-1H, AN INTERLEUKIN 1-RELATED PROTEIN THAT BINDS IL-18 RECEPTOR/IL-1Rrp
Pan, G., Risser, P., Mao, W., Baldwin, D. T., Zhong, A. W., Filvaroff, E., Yansura, D., Lewis, L., Eigenbrot, C., Henzel, W. J., et al. (2001) · Cytokine · doi:10.1006/cyto.2000.0799 · Cited by 210
Interleukin-1 and Cutaneous Inflammation: A Crucial Link Between Innate and Acquired Immunity
Murphy, J.-E., Robert, C., & Kupper, T. S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00917.x · Cited by 201
Rich, P., Sigurgeirsson, B., Thaci, D. P., Ortonne, J.-P., Paul, C., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12070 · Cited by 189
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
Luger, T. A., Stadler, B. M., Luger, B. M., Mathieson, B. J., Mage, M., Schmidt, J. A., & Oppenheim, J. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.5.2147 · Cited by 182
Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes
Setta-Kaffetzi, N., Navarini, A. A., Patel, V. M., Pullabhatla, V., Pink, A. E., Choon, S.-E., Allen, M. A., Burden, A. D., Griffiths, C. E. M., Seyger, M. M. B., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.490 · Cited by 172
IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
Witte, E., Kokolakis, G., Witte, K., Philipp, S., Doecke, W.-D., Babel, N., Wittig, B. M., Warszawska, K., Kurek, A., Erdmann-Keding, M., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.308 · Cited by 164
Teunissen, M. B. M., Yeremenko, N. G., Baeten, D. L. P., Chielie, S., Spuls, P. I., de Rie, M. A., Lantz, O., & Res, P. C. M. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.261 · Cited by 164
Skepner, J. E., Ramesh, R., Trocha, M., Schmidt, D. R., Baloglu, E., Lobera, M., Carlson, T. J., Hill, J. A., Orband‐Miller, L. A., Barnes, A. A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302190 · Cited by 155
Genomic Organization of the Interleukin-1 Locus
Taylor, S. L., Renshaw, B. R., Garka, K. E., Smith, D. E., & Sims, J. E. (2002) · Genomics · doi:10.1006/geno.2002.6752 · Cited by 154
Magne, D., Palmer, G., Barton, J. L., Mézin, F., Talabot‐Ayer, D., Bas, S., Duffy, T., Noger, M., Guerne, P., Nicklin, M. J. H., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1946 · Cited by 146
The role of neuropeptides in psoriasis
Saraceno, R., Kleyn, C. E., Terenghi, G., & Griffiths, C. E. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07518.x · Cited by 145
Myles, I. A., Fontecilla, N. M., Valdez, P. A., Vithayathil, P. J., Naik, S., Belkaid, Y., Ouyang, W., & Datta, S. K. (2013) · Nature Immunology · doi:10.1038/ni.2637 · Cited by 140
Cytokines in skin lesions of psoriasis
Gearing, A. J. H. (1990) · Cytokine · doi:10.1016/1043-4666(90)90045-u · Cited by 137
Transcriptional responses of human epidermal keratinocytes to cytokine interleukin‐1
Yano, S., Banno, T., Walsh, R., & Blumenberg, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21300 · Cited by 135
Nickoloff, B. J., Bonish, B. K., Huang, B. B., & Porcelli, S. A. (2000) · Journal of Dermatological Science · doi:10.1016/s0923-1811(00)00120-1 · Cited by 129
Bata‐Csörgõ, Z., Hammerberg, C., Voorhees, J. J., & Cooper, K. D. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.4.1271 · Cited by 128
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
Hammerberg, C., Arend, W. P., Fisher, G. J., Chan, L. S., Berger, A. E., Haskill, J. S., Voorhees, J. J., & Cooper, K. D. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115896 · Cited by 126
Johnson-Huang, L. M., Suárez‐Fariñas, M., Pierson, K. C., Fuentes‐Duculan, J., Cueto, I., Lentini, T., Sullivan-Whalen, M. M., Gilleaudeau, P., Krueger, J. G., Haider, A. S., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.458 · Cited by 120
Mee, J. B., Johnson, C. M., Morar, N., Burslem, F., & Groves, R. W. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061067 · Cited by 106
Nickoloff, B. J., Mitra, R. S., Elder, J. T., Fisher, G. J., & Voorhees, J. J. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01795.x · Cited by 105
Mutamba, S., Allison, A., Mahida, Y. R., Barrow, P., & Foster, N. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201142035 · Cited by 104
Sigmundsdóttir, H., Gudjonsson, J. E., Jónsdóttir, I., Ludviksson, B. R., & Valdimarsson, H. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01688.x · Cited by 103
Papp, K. A., Poulin, Y. P., Bissonnette, R., Bourcier, M., Toth, D. P., Rosoph, L., Poulin-Costello, M., Setterfield, M., & Syrotuik, J. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.07.026 · Cited by 100
Purwar, R., Werfel, T., & Wittmann, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700085 · Cited by 99
Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis
Swindell, W. R., Xing, X., Stuart, P. E., Chen, C. S., Aphale, A., Nair, R. P., Voorhees, J. J., Elder, J. T., Johnston, A. W. B., & Gudjonsson, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034594 · Cited by 96
Self-citationBissonnette, R., Papp, K. A., Maari, C., Yao, Y., Robbie, G. J., White, W. I., Le, C., & White, B. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.042 · Cited by 93
Afshar, M., Martinez, A. D., Gallo, R. L., & Hata, T. R. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04582.x · Cited by 81
Integrated network analysis of transcriptomic and proteomic data in psoriasis
Пирузян, Э. С., Bruskin, S. A., Ishkin, A., Abdeev, R. M., Moshkovskii, S. A., Melnik, S., Nikolsky, Y., & Nikolskaya, T. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-41 · Cited by 75
Structural basis of IL-23 antagonism by an Alphabody protein scaffold
Desmet, J., Verstraete, K., Bloch, Y., Lorent, E., Wen, Y., Devreese, B. V., Vandenbroucke, K., Loverix, S., Hettmann, T., Deroo, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6237 · Cited by 71
Jung, N., Hellmann, M., Hoheisel, R., Lehmann, C., Haase, I., Perniok, A., Hallek, M. J., & RUBBERT, A. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1504-5 · Cited by 66
IL-13Rα2 Membrane and Soluble Isoforms Differ in Humans and Mice
Chen, W., Sivaprasad, U., Tabata, Y., Gibson, A. M., Stier, M. T., Finkelman, F. D., & Hershey, G. K. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901028 · Cited by 65
A Systems Model for Immune Cell Interactions Unravels the Mechanism of Inflammation in Human Skin
Valeyev, N. V., Hundhausen, C., Umezawa, Y., Kotov, N. V., Williams, G. H., Clop, A., Ainali, C., Ouzounis, C., Tsoka, S., & Nestle, F. O. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001024 · Cited by 63
Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era
Swindell, W. R., Stuart, P. E., Sarkar, M. K., Voorhees, J. J., Elder, J. T., Johnston, A. W. B., & Gudjonsson, J. E. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-27 · Cited by 58
Self-citationA New Player on the Psoriasis Block: IL-17A- and IL-22-Producing Innate Lymphoid Cells
Ward, N. L., & Umetsu, D. T. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.216 · Cited by 56
Johnston, A. W. B., Guzman, A. M., Swindell, W. R., Wang, F., Kang, S., & Gudjonsson, J. E. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12937 · Cited by 56
Self-citationNikamo, P., Cheuk, S., Lysell, J., Enerbäck, C., Bergh, K., Xu, N., Eidsmo, L., & Ståhle, M. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.5 · Cited by 53
Novel systemic drugs under investigation for the treatment of psoriasis
Gudjonsson, J. E., Johnston, A. W. B., & Ellis, C. N. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.06.037 · Cited by 46
Self-citationSusceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis
Johnston, A., Xing, X., Swindell, W. R., Kochkodan, J. J., Riblett, M., Nair, R. P., Stuart, P. E., Ding, J., Voorhees, J. J., Elder, J. T., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt034 · Cited by 45
Self-citationTurka, L. A., Goodman, R. E., Rutkowski, J. L., Sima, A. A. F., Merry, A. C., Mitra, R. S., Wrone-Smith, T., Toews, G., Strieter, R. M., & Nickoloff, B. J. (1995) · Molecular Medicine · doi:10.1007/bf03401609 · Cited by 30
Quiniou, C., Domínguez-Punaro, M. D. L. C., Cloutier, F., Erfani, A., Ennaciri, J., Sivanesan, D., Sanchez, M., Chognard, G., Hou, X., Rivera, J. C., et al. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00540.2013 · Cited by 29
Sigmundsdóttir, H., Johnston, A. W. B., Gudjonsson, J. E., & Valdimarsson, H. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.01.003 · Cited by 16
Self-citation
Cited by
Management of psoriasis as a systemic disease: what is the evidence?
Korman, N. J. (2020) · British Journal of Dermatology · doi:10.1111/bjd.18245 · Cited by 539
Pathological angiogenesis: mechanisms and therapeutic strategies
Dudley, A. C., & Griffioen, A. W. (2023) · Angiogenesis · doi:10.1007/s10456-023-09876-7 · Cited by 495
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
Virtanen, A. T., Haikarainen, T., Raivola, J., & Silvennoinen, O. (2019) · BioDrugs · doi:10.1007/s40259-019-00333-w · Cited by 281
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Li, H., Guan, Y., Liang, B., Ding, P., Hou, X., Wei, W., & Ma, Y. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175091 · Cited by 258
Organization of the skin immune system and compartmentalized immune responses in infectious diseases
Quaresma, J. A. S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-18 · Cited by 149
Metadata
- Authors
- Baliwag, J., Barnes, D. H., & Johnston, A.
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 73
- Issue
- 2
- Pages
- 342-350
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W2063512593
- Cited by
- 373
- References
- 122
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.